Farzan Nima 4
4 · Keros Therapeutics, Inc. · Filed May 29, 2020
Insider Transaction Report
Form 4
Farzan Nima
Director
Transactions
- Award
Stock Option (right to buy)
2020-05-29+8,500→ 8,500 totalExercise: $28.74Exp: 2030-05-29→ Common Stock (8,500 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on each of June 2, 2020, September 2, 2020, December 2, 2020 and March 2, 2021, subject to the Reporting Person continuing to provide service through each such date.